AB055. SOH24AB_245. Value of Pre-Treatment Circulating Inflammatory Response Markers in Predicting Response to Neoadjuvant Treatment of Breast Cancer: a Systematic Review & Meta-Analysis

Background: Systemic inflammatory response markers have been found to have a prognostic role in several cancers, but their value in predicting response to neoadjuvant chemotherapy is uncertain. A systematic review and meta-analysis of the literature was carried out to investigate this.